Central Pennsylvania Blood is categorized under Blood Banks and Centers in Ephrata, PA .
Central Pennsylvania Blood was established in 0, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Blood Banks and Centers business, which does work in the B2C market, and is classified as a Blood Banks and Centers, under code number 6219910 by the NAICS.
If you are seeking more information, feel free to contact Christine Priggins at the company’s single location by writing to 95 North Reading Road, Ephrata, Pennsylvania PA 17522 or by phoning (717) 733-3200. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Central Pennsylvania Blood |
| Contact Person: | Christine Priggins |
| Address: | 95 North Reading Road, Ephrata, Pennsylvania 17522 |
| Phone Number: | (717) 733-3200 |
| Website Address: | cpbb.org |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Blood Banks and Centers |
| SIC Code: | 8099 |
| NAICS Code: | 6219910 |
| Share This Business: |
Central Pennsylvania Blood was started in 0 to provide professional Blood Banks and Centers under the SIC code 8099 and NAICS code 6219910. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Christine Priggins for inquiries that concern Central Pennsylvania Blood by calling the company number (717) 733-3200, as your correspondence is most welcome. Additionally, the physical location of the single location of Central Pennsylvania Blood can be found at the coordinates 40.18707,-76.18478 as well as the street address 95 North Reading Road in Ephrata, Pennsylvania 17522.
For its online presence, you may visit Central Pennsylvania Blood’s website at cpbb.org and engage with its social media outlets through on Twitter and on Facebook.